Human platelet calcium mobilisation in response to β-amyloid (25-35): Buffer dependency and unchanged response in Alzheimer's disease

Neurochemistry International

Volumn 38, Issue 2, 2001, Pages 145-151

  Hedin, Henrietta L M ^a   Eriksson, Sture ^a   Fowler, Christopher J ^a  

^a UMEÅ UNIVERSITY   (Sweden)

Author keywords

Alzheimer's disease; Amyloid beta peptides; Platelets; Serotonin; U 73122

Indexed keywords

1 [[6 (3 METHOXYESTRA 1,3,5(10) TRIEN 17BETA YL)AMINO]HEXYL] 1H PYRROLE 2,5 DIONE; 4 (2 HYDROXYETHYL) 1 PIPERAZINEETHANESULFONIC ACID; AMYLOID BETA PROTEIN; BUFFER; PHOSPHOLIPASE C INHIBITOR; SEROTONIN;

ADULT; AGED; ALZHEIMER DISEASE; ARTICLE; CALCIUM CELL LEVEL; CALCIUM MOBILIZATION; CLINICAL ARTICLE; CONTROLLED STUDY; EXTRACELLULAR CALCIUM; FEMALE; HUMAN; HUMAN CELL; MALE; PH; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; THROMBOCYTE;

ADULT; AGED; AGED, 80 AND OVER; ALZHEIMER DISEASE; AMYLOID BETA-PROTEIN; BIOLOGICAL TRANSPORT; BLOOD PLATELETS; BUFFERS; CALCIUM; CALCIUM CHANNEL BLOCKERS; ESTRENES; EXTRACELLULAR SPACE; FEMALE; HEPES; HUMANS; MALE; MIDDLE AGED; OSMOLAR CONCENTRATION; PEPTIDE FRAGMENTS; PYRROLIDINONES; REFERENCE VALUES; SEROTONIN;

EID: 0035255082     PISSN: 01970186     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0197-0186(00)00068-1     Document Type: Article

References (34)

1. 2+-dependent late phase
2. Über eine eigenartige erkrankung der hirnrinde
3. Alzheimer's disease amyloid β-protein forms calcium channels in bilayer membranes: Blockade by thromethamine and aluminium
4. Selective inhibition of receptor-coupled phospholipase C-dependent processes in human platelets and polymorphonuclear neutrophils
5. Predicting the in vitro toxicity of synthetic beta-amyloid (1-40)
6. Fluorescence and bioluminescence measurement of cytoplasmic free calcium
7. Abnormal platelet membrane composition in Alzheimer's-type dementia
8. Conformations of β-amyloid in solution
9. "Mini-mental state". A practical method for grading the cognitive state of patients for the clinician
10. Serotonin-stimulated calcium responses in human platelets: Assay buffer dependency
11. Comparison of the effects of hydrogen peroxide, 4-hydroxy-2-nonenal and β-amyloid (25-35) upon calcium signalling
12. 2A receptor density
13. Calcium-sensitive probes for the measurement of intracellular calcium: Effects of buffer system and magnesium concentration
14. 2+ indicators with greatly improved fluorescence properties
15. Platelet and erythrocyte membrane changes in Alzheimer's disease
16. A model for beta-amyloid aggregation and neurotoxicity based on free radical generation by the peptide: Relevance to Alzheimer's disease
17. Calcium mobilization evoked by amyloid β-protein involves inositol 1,4,5-trisphosphate production in human platelets
18. Conformations of β-amyloid in solution; reply
19. 2+ response in human platelets
20. The phospholipase C inhibitor U-73122 inhibits phorbol ester-induced platelet activation
21. Cellular actions of β-amyloid precursor protein and its soluble and fibrillogenic derivatives
22. 2+ release and directly activates ion channels in mouse pancreatic acinar cells
23. Reduction in somatostatin and substance P levels and choline acetyltransferase activity in the cortex and hippocampus of the rat after chronic intracerebroventricular infusion of β-amyloid (1-40)
24. 2+ store depletion in human platelets in more susceptible to cytochrome P 450 inhibitors than receptor mediated calcium entry
25. Solvent effects on self-assembly of beta-amyloid peptide
26. Amyloid β protein (25-35) stimulation of phospholipase C in LA-N-2 cells
27. Induction of CD40 on human endothelial cells by Alzheimer's β-amyloid peptides
28. 2+ signalling: Problems and pitfalls
29. 2+ channels: A possible involvement of free radicals
30. Effects of Alzheimer's disease-related β-amyloid protein fragments on enzymes metabolising phosphoinositides in brain
31. 2+-permeable channels through calcium-sensing receptors
32. Actions of neurotoxic β-amyloid on calcium homeostasis and viability of PC12 cells are blocked by antioxidants but not by calcium channel antagonists
33. Cell membrane abnormality in Alzheimer's disease